Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression: A Randomized Controlled Trial

NCT07626892 is registered in ClinicalTrials.gov with Khyber Medical College, Peshawar as lead sponsor.

NCT NCT07626892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07626892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression: A Randomized Controlled Trial
Lead sponsor
Khyber Medical College, Peshawar
Phase
Phase 3
Overall status
Completed
Start date
June 3, 2024
Completion date
May 22, 2026
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atropine, myopia progression